BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing CODIT™ (characterized oral desensitization immunotherapy) treatments for life-threatening food allergies, today announced the appointment of Douglas Sheehy as General Counsel and Secretary. Mr. Sheehy has more than 20 years of both in-house and law firm experience, including nearly a decade as general counsel.
